MEDINDIA
English
हिन्दी
Español
français
中文
Email
Acarbose
Methyltestosterone may increase the hypoglycemic activities of Acarbose.
Acenocoumarol
Methyltestosterone may increase the anticoagulant activities of Acenocoumarol.
Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Methyltestosterone.
Albiglutide
Methyltestosterone may increase the hypoglycemic activities of Albiglutide.
Alclometasone
Alclometasone may increase the fluid retaining activities of Methyltestosterone.
Aldosterone
Aldosterone may increase the fluid retaining activities of Methyltestosterone.
Alogliptin
Methyltestosterone may increase the hypoglycemic activities of Alogliptin.
Amcinonide
Amcinonide may increase the fluid retaining activities of Methyltestosterone.
Amiodarone
The metabolism of Methyltestosterone can be decreased when combined with Amiodarone.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Methyltestosterone.
Androstenedione
Androstenedione may increase the fluid retaining activities of Methyltestosterone.
Apalutamide
The serum concentration of Methyltestosterone can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Methyltestosterone can be increased when it is combined with Aprepitant.
Atazanavir
The metabolism of Methyltestosterone can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Methyltestosterone can be decreased when combined with Atomoxetine.
Beclomethasone Dipropionate
Beclomethasone dipropionate may increase the fluid retaining activities of Methyltestosterone.
Betamethasone
Betamethasone may increase the fluid retaining activities of Methyltestosterone.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Methyltestosterone.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Methyltestosterone.
Boceprevir
The metabolism of Methyltestosterone can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Methyltestosterone can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Methyltestosterone can be decreased when it is combined with Bosentan.
Bromocriptine
Methyltestosterone may increase the hypoglycemic activities of Bromocriptine.
Budesonide
Budesonide may increase the fluid retaining activities of Methyltestosterone.
C1 esterase inhibitor (human)
Methyltestosterone may increase the thrombogenic activities of Human C1-esterase inhibitor.
C1 esterase inhibitor (recombinant)
Methyltestosterone may increase the thrombogenic activities of Conestat alfa.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Methyltestosterone.
Canagliflozin
Methyltestosterone may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Methyltestosterone may increase the hypoglycemic activities of Canagliflozin.
Carbamazepine
The metabolism of Methyltestosterone can be increased when combined with Carbamazepine.
Ceritinib
The serum concentration of Methyltestosterone can be increased when it is combined with Ceritinib.
Chlorpropamide
Methyltestosterone may increase the hypoglycemic activities of Chlorpropamide.
Ciclesonide
Ciclesonide may increase the fluid retaining activities of Methyltestosterone.
Citalopram
The metabolism of Methyltestosterone can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Methyltestosterone can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Methyltestosterone can be decreased when combined with Clemastine.
Clobetasol
Clobetasol may increase the fluid retaining activities of Methyltestosterone.
Clobetasol Propionate
Clobetasol propionate may increase the fluid retaining activities of Methyltestosterone.
Clobetasone
Clobetasone may increase the fluid retaining activities of Methyltestosterone.
Clocortolone
Clocortolone may increase the fluid retaining activities of Methyltestosterone.
Clopidogrel
The metabolism of Methyltestosterone can be decreased when combined with Clopidogrel.
Clotrimazole
The metabolism of Methyltestosterone can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Methyltestosterone can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Methyltestosterone.
Cortisone Acetate
Cortisone acetate may increase the fluid retaining activities of Methyltestosterone.
Crizotinib
The metabolism of Methyltestosterone can be decreased when combined with Crizotinib.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Methyltestosterone.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Methyltestosterone.
Cyclosporine
Methyltestosterone may increase the hepatotoxic activities of Cyclosporine.
Dabrafenib
The serum concentration of Methyltestosterone can be decreased when it is combined with Dabrafenib.
Dapagliflozin
Methyltestosterone may increase the hypoglycemic activities of Dapagliflozin.
Darunavir
The metabolism of Methyltestosterone can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Methyltestosterone can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Methyltestosterone can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Methyltestosterone can be decreased when it is combined with Deferasirox.
Deflazacort
Deflazacort may increase the fluid retaining activities of Methyltestosterone.
Delavirdine
The metabolism of Methyltestosterone can be decreased when combined with Delavirdine.
Desipramine
The metabolism of Methyltestosterone can be decreased when combined with Desipramine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Methyltestosterone.
Desonide
Desonide may increase the fluid retaining activities of Methyltestosterone.
Desoximetasone
Desoximetasone may increase the fluid retaining activities of Methyltestosterone.
Desoxycorticosterone acetate
Desoxycorticosterone acetate may increase the fluid retaining activities of Methyltestosterone.
Desoxycorticosterone Pivalate
Desoxycorticosterone Pivalate may increase the fluid retaining activities of Methyltestosterone.
Dexamethasone
Dexamethasone may increase the fluid retaining activities of Methyltestosterone.
Dicumarol
Methyltestosterone may increase the anticoagulant activities of Dicoumarol.
Diflorasone
Diflorasone may increase the fluid retaining activities of Methyltestosterone.
Diflucortolone
Difluocortolone may increase the fluid retaining activities of Methyltestosterone.
Difluprednate
Difluprednate may increase the fluid retaining activities of Methyltestosterone.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Methyltestosterone.
Digoxin
Digoxin may decrease the cardiotoxic activities of Methyltestosterone.
Dihydroergotamine
The metabolism of Methyltestosterone can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Methyltestosterone can be decreased when combined with Diltiazem.
Disopyramide
Methyltestosterone may increase the hypoglycemic activities of Disopyramide.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Methyltestosterone.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Methyltestosterone.
Doxorubicin
The metabolism of Methyltestosterone can be decreased when combined with Doxorubicin.
Doxorubicin Hydrochloride
The metabolism of Methyltestosterone can be decreased when combined with Doxorubicin.
Doxycycline
The metabolism of Methyltestosterone can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Methyltestosterone can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Methyltestosterone can be decreased when combined with Dronedarone.
Dulaglutide
Methyltestosterone may increase the hypoglycemic activities of Dulaglutide.
Empagliflozin
Methyltestosterone may increase the hypoglycemic activities of Empagliflozin.
Enzalutamide
The serum concentration of Methyltestosterone can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Methyltestosterone can be decreased when combined with Erythromycin.
Estrone
Estrone may increase the fluid retaining activities of Methyltestosterone.
Exenatide
Methyltestosterone may increase the hypoglycemic activities of Exenatide.
Fluconazole
The metabolism of Methyltestosterone can be decreased when combined with Fluconazole.
Fludrocortisone
Fludrocortisone may increase the fluid retaining activities of Methyltestosterone.
Fluindione
Methyltestosterone may increase the anticoagulant activities of Fluindione.
Flumethasone
Flumethasone may increase the fluid retaining activities of Methyltestosterone.
Flunisolide
Flunisolide may increase the fluid retaining activities of Methyltestosterone.
Flunisolide Anhydrous (obsolete)
Flunisolide may increase the fluid retaining activities of Methyltestosterone.
Fluocinolone Acetonide
Fluocinolone Acetonide may increase the fluid retaining activities of Methyltestosterone.
Fluocinonide
Fluocinonide may increase the fluid retaining activities of Methyltestosterone.
Fluocortolone
Fluocortolone may increase the fluid retaining activities of Methyltestosterone.
Fluorometholone
Fluorometholone may increase the fluid retaining activities of Methyltestosterone.
FLUPREDNIDENE
Fluprednidene may increase the fluid retaining activities of Methyltestosterone.
Fluprednisolone
Fluprednisolone may increase the fluid retaining activities of Methyltestosterone.
Flurandrenolide
Flurandrenolide may increase the fluid retaining activities of Methyltestosterone.
Fluticasone Furoate
Fluticasone furoate may increase the fluid retaining activities of Methyltestosterone.
Fluticasone propionate
Fluticasone propionate may increase the fluid retaining activities of Methyltestosterone.
Fluvoxamine
The metabolism of Methyltestosterone can be decreased when combined with Fluvoxamine.
Formestane
Formestane may increase the fluid retaining activities of Methyltestosterone.
Fosamprenavir
The metabolism of Methyltestosterone can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Methyltestosterone can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Methyltestosterone can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Methyltestosterone can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Methyltestosterone can be increased when it is combined with Fusidic Acid.
Gliclazide
Methyltestosterone may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Methyltestosterone may increase the hypoglycemic activities of Glimepiride.
Glipizide
Methyltestosterone may increase the hypoglycemic activities of Glipizide.
Glyburide
Methyltestosterone may increase the hypoglycemic activities of Glyburide.
Halcinonide
Halcinonide may increase the fluid retaining activities of Methyltestosterone.
Halobetasol
Ulobetasol may increase the fluid retaining activities of Methyltestosterone.
Hydrocortisone
Hydrocortisone may increase the fluid retaining activities of Methyltestosterone.
Hypoxis hemerocallidea root extract
The serum concentration of Methyltestosterone can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Methyltestosterone can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Methyltestosterone can be decreased when combined with Imatinib.
Indinavir
The metabolism of Methyltestosterone can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Methyltestosterone can be decreased when combined with Indinavir.
Insulin Detemir
Methyltestosterone may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Methyltestosterone may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Methyltestosterone may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Methyltestosterone may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Methyltestosterone may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Methyltestosterone may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Methyltestosterone may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Methyltestosterone may increase the hypoglycemic activities of Insulin Lispro.
Isavuconazole
The serum concentration of Methyltestosterone can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Methyltestosterone can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Methyltestosterone can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Methyltestosterone can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Methyltestosterone can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Methyltestosterone can be decreased when combined with Ketoconazole.
Liraglutide
Methyltestosterone may increase the hypoglycemic activities of Liraglutide.
Lopinavir
The metabolism of Methyltestosterone can be decreased when combined with Lopinavir.
Loteprednol
Loteprednol may increase the fluid retaining activities of Methyltestosterone.
Lovastatin
The metabolism of Methyltestosterone can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Methyltestosterone can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Methyltestosterone can be decreased when it is combined with Lumacaftor.
Mecasermin
Methyltestosterone may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Methyltestosterone may increase the hypoglycemic activities of Mecasermin.
Medrysone
Medrysone may increase the fluid retaining activities of Methyltestosterone.
Metformin
Methyltestosterone may increase the hypoglycemic activities of Metformin.
Methylprednisolone
Methylprednisolone may increase the fluid retaining activities of Methyltestosterone.
Mifepristone
The serum concentration of Methyltestosterone can be increased when it is combined with Mifepristone.
Miglitol
Methyltestosterone may increase the hypoglycemic activities of Miglitol.
Mitotane
The serum concentration of Methyltestosterone can be decreased when it is combined with Mitotane.
Mometasone
Mometasone may increase the fluid retaining activities of Methyltestosterone.
Nateglinide
Methyltestosterone may increase the hypoglycemic activities of Nateglinide.
Nefazodone
The metabolism of Methyltestosterone can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Methyltestosterone can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Methyltestosterone can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Methyltestosterone can be increased when combined with Nevirapine.
Nilotinib
The metabolism of Methyltestosterone can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Methyltestosterone can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Methyltestosterone can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Methyltestosterone.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Methyltestosterone.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Methyltestosterone.
Palbociclib
The serum concentration of Methyltestosterone can be increased when it is combined with Palbociclib.
Paramethasone
Paramethasone may increase the fluid retaining activities of Methyltestosterone.
Paroxetine
The metabolism of Methyltestosterone can be decreased when combined with Paroxetine.
Pentamidine
Methyltestosterone may increase the hypoglycemic activities of Pentamidine.
Pentobarbital
The metabolism of Methyltestosterone can be increased when combined with Pentobarbital.
Phenindione
Methyltestosterone may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Methyltestosterone can be increased when combined with Phenobarbital.
Phenprocoumon
Methyltestosterone may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The metabolism of Methyltestosterone can be increased when combined with Phenytoin.
Pioglitazone
Methyltestosterone may increase the hypoglycemic activities of Pioglitazone.
Posaconazole
The metabolism of Methyltestosterone can be decreased when combined with Posaconazole.
Pramlintide
Methyltestosterone may increase the hypoglycemic activities of Pramlintide.
Prasterone
Prasterone may increase the fluid retaining activities of Methyltestosterone.
Prednicarbate
Prednicarbate may increase the fluid retaining activities of Methyltestosterone.
Prednisolone
Prednisolone may increase the fluid retaining activities of Methyltestosterone.
Prednisone
Prednisone may increase the fluid retaining activities of Methyltestosterone.
Pregnenolone
Pregnenolone may increase the fluid retaining activities of Methyltestosterone.
Primidone
The metabolism of Methyltestosterone can be increased when combined with Primidone.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Methyltestosterone.
Quazepam
The serum concentration of Methyltestosterone can be increased when it is combined with Quazepam.
Quinine
Methyltestosterone may increase the hypoglycemic activities of Quinine.
Ranolazine
The metabolism of Methyltestosterone can be decreased when combined with Ranolazine.
Regular Insulin, Human
Methyltestosterone may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Methyltestosterone may increase the hypoglycemic activities of Repaglinide.
Rifabutin
The metabolism of Methyltestosterone can be increased when combined with Rifabutin.
Rifampin
The metabolism of Methyltestosterone can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Methyltestosterone can be increased when combined with Rifapentine.
Rimexolone
Rimexolone may increase the fluid retaining activities of Methyltestosterone.
Rosiglitazone
Methyltestosterone may increase the hypoglycemic activities of Rosiglitazone.
Rucaparib
The metabolism of Methyltestosterone can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Methyltestosterone can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Methyltestosterone can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Methyltestosterone can be decreased when used in combination with Sarilumab.
Saxagliptin
Methyltestosterone may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Methyltestosterone may increase the hypoglycemic activities of Saxagliptin.
Sertraline
The metabolism of Methyltestosterone can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Methyltestosterone can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Methyltestosterone can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Methyltestosterone can be increased when it is combined with Simeprevir.
Sitagliptin
Methyltestosterone may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Methyltestosterone may increase the hypoglycemic activities of Sitagliptin.
Sorafenib
The metabolism of Methyltestosterone can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Methyltestosterone can be decreased when it is combined with St. John's Wort.
Sulfadiazine
Methyltestosterone may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Methyltestosterone may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
The metabolism of Methyltestosterone can be decreased when combined with Sulfisoxazole.
Sunitinib
Methyltestosterone may increase the hypoglycemic activities of Sunitinib.
Telaprevir
The metabolism of Methyltestosterone can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Methyltestosterone can be decreased when combined with Telithromycin.
Thiotepa
The metabolism of Methyltestosterone can be decreased when combined with Thiotepa.
Ticlopidine
The metabolism of Methyltestosterone can be decreased when combined with Ticlopidine.
Tixocortol
Tixocortol may increase the fluid retaining activities of Methyltestosterone.
Tocilizumab
The serum concentration of Methyltestosterone can be decreased when it is combined with Tocilizumab.
Tolazamide
Methyltestosterone may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Methyltestosterone may increase the hypoglycemic activities of Tolbutamide.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Methyltestosterone.
Triamcinolone
Triamcinolone may increase the fluid retaining activities of Methyltestosterone.
Vemurafenib
The serum concentration of Methyltestosterone can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Methyltestosterone can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Methyltestosterone can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Methyltestosterone can be decreased when combined with Voriconazole.
Warfarin
Methyltestosterone may increase the anticoagulant activities of Warfarin.
Ziprasidone
The metabolism of Methyltestosterone can be decreased when combined with Ziprasidone.
